{"disease":{"id":"arterial-hypertension","name":"arterial hypertension"},"drugs":{"marketed":[{"drug_id":"treprostinil","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Remodulin","generic_name":"TREPROSTINIL","company_name":"United Therap","drug_phase":"marketed","molecular_target":"Prostacyclin receptor","drug_class":"Prostacycline Vasodilator [EPC]","quality_score":10,"revenue":"2000","mechanism":"Remodulin works by activating the prostacyclin receptor, which causes blood vessels to relax and widen."},{"drug_id":"sotatercept","indication_name":"pulmonary arterial hypertension (PAH, Group 1 pulmonary hypertension)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Winrevair","generic_name":"SOTATERCEPT","company_name":"Merck Sharp Dohme","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":45,"revenue":"1443","mechanism":"Winrevair works by binding to and inhibiting the activity of activin receptors, which play a role in the development of pulmonary arterial hypertension."},{"drug_id":"sotatercept","indication_name":"pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Winrevair","generic_name":"SOTATERCEPT","company_name":"Merck Sharp Dohme","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":45,"revenue":"1443","mechanism":"Winrevair works by binding to and inhibiting the activity of activin receptors, which play a role in the development of pulmonary arterial hypertension."},{"drug_id":"macitentan","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Opsumit","generic_name":"MACITENTAN","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Endothelin-1 receptor","drug_class":"Endothelin Receptor Antagonist [EPC]","quality_score":75,"revenue":"1181.0","mechanism":"Opsumit works by blocking the action of endothelin-1, a protein that causes blood vessels to constrict and increase blood pressure."},{"drug_id":"adempas","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Adempas","company_name":"University of Colorado, Denver","drug_phase":"marketed","molecular_target":"Guanylate cyclase soluble subunit beta-1, cAMP-specific 3',5'-cyclic phosphodiesterase 7B","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"beraprost","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Procylin","generic_name":"BERAPROST","company_name":"","drug_phase":"discontinued","molecular_target":"Prostacyclin receptor","drug_class":"beraprost","quality_score":null,"revenue":null,"mechanism":"Procylin works by activating the prostacyclin receptor, which helps to relax blood vessels and improve blood flow."},{"drug_id":"revatio","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Revatio","generic_name":"Sildenafil Citrate","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Phosphodiesterase type 5 (PDE5)","drug_class":"PDE5 inhibitor","quality_score":66,"revenue":null,"mechanism":"Sildenafil inhibits phosphodiesterase type 5 (PDE5), increasing cGMP levels and enabling penile smooth muscle relaxation."},{"drug_id":"epoprostenol","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Flolan","generic_name":"EPOPROSTENOL","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Prostacyclin receptor","drug_class":"Prostacycline Vasodilator [EPC]","quality_score":75,"revenue":null,"mechanism":"Flolan works by binding to the prostacyclin receptor, causing blood vessels to relax and dilate."},{"drug_id":"ambrisentan","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Letairis","generic_name":"AMBRISENTAN","company_name":"Gilead Sciences","drug_phase":"marketed","molecular_target":"Endothelin-1 receptor","drug_class":"Endothelin Receptor Antagonist [EPC]","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"selexipag","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Uptravi","generic_name":"SELEXIPAG","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Prostacyclin receptor","drug_class":"Prostacyclin Receptor Agonist [EPC]","quality_score":70,"revenue":null,"mechanism":"Uptravi works by activating the prostacyclin receptor, which helps to relax blood vessels and improve blood flow."},{"drug_id":"riociguat","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Adempas","generic_name":"RIOCIGUAT","company_name":"Bayer","drug_phase":"marketed","molecular_target":"Guanylate cyclase soluble subunit beta-1","drug_class":"Soluble Guanylate Cyclase Stimulator [EPC]","quality_score":10,"revenue":null,"mechanism":"Adempas works by stimulating the soluble guanylate cyclase enzyme to increase levels of cyclic guanosine monophosphate (cGMP), a signaling molecule that helps to relax blood vessels."},{"drug_id":"sitaxsentan","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Sitaxsentan","company_name":"Pfizer","drug_phase":"discontinued","molecular_target":"Endothelin B receptor, Endothelin-1 receptor, Endothelin-1 receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"ventavis","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ventavis","company_name":"Meshalkin Research Institute of Pathology of Circulation","drug_phase":"phase_2","molecular_target":"Prostacyclin receptor, Prostaglandin D2 receptor, Prostaglandin E2 receptor EP1 subtype","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"sildenafil","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Viagra","generic_name":"sildenafil","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, Multidrug resistance-associated protein 5","drug_class":"PDE5 inhibitor","quality_score":null,"revenue":null,"mechanism":"Selectively inhibits phosphodiesterase type 5 (PDE5), increasing cGMP levels to relax smooth muscle in the corpus cavernosum and pulmonary vasculature."},{"drug_id":"sotatercept-csrk","indication_name":"Pulmonary Arterial Hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"WINREVAIR","generic_name":"SOTATERCEPT-CSRK","company_name":"MERCK SHARP DOHME","drug_phase":"marketed","molecular_target":"activin A and other TGF-β superfamily ligands","drug_class":"","quality_score":46,"revenue":null,"mechanism":"Sotatercept-csrk binds to activin A and other TGF-β superfamily ligands, improving the balance between pro-proliferative and anti-proliferative signaling to modulate vascular proliferation."},{"drug_id":"bosentan","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tracleer","generic_name":"BOSENTAN","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Endothelin-1 receptor","drug_class":"Endothelin Receptor Antagonist","quality_score":52,"revenue":null,"mechanism":""},{"drug_id":"prostacyclin","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prostacyclin","company_name":"United Therapeutics","drug_phase":"marketed","molecular_target":"P2Y purinoceptor 12, Prostacyclin receptor, Prostaglandin E2 receptor EP1 subtype","drug_class":"","quality_score":23,"revenue":null,"mechanism":null},{"drug_id":"ilomedin","indication_name":"Pulmonary arterial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ilomedin","company_name":"Prim PD Dr Afshin Assadian","drug_phase":"phase_2","molecular_target":"Prostacyclin receptor, Prostaglandin D2 receptor, Prostaglandin E2 receptor EP1 subtype","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[{"drug_id":"chlorthalidone","indication_name":"Efficacy and safety of olmesartan associated with chlorthalidone in essential arterial hypertension","indication_type":"pipeline","phase":"Phase 3","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CHLORTHALIDONE","company_name":"","drug_phase":"marketed","molecular_target":"Na+/Cl− cotransporter","drug_class":"Thiazide-like Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":18,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT01347216","title":"COMPERA / COMPERA-KIDS","phase":"","overall_status":"RECRUITING","enrollment_count":14000,"lead_sponsor_name":"Technische Universität Dresden","has_results":false},{"nct_id":"NCT05039086","title":"Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - PDE5","phase":"","overall_status":"COMPLETED","enrollment_count":13021,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":true},{"nct_id":"NCT06769269","title":"Hypertension Registry: Study of Primary and Secondary Hypertension Phenotypes, Complications, and Treatment Personalization.","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Moroccan Society of Cardiology","has_results":false},{"nct_id":"NCT07217522","title":"Rutgers University Study of the Genetics of Pulmonary Hypertension","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":false},{"nct_id":"NCT06528418","title":"Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"ChromX Health","has_results":false},{"nct_id":"NCT06954727","title":"China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-right Heart Catheterization","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT05651724","title":"Global Research Initiative for Patients Screening on MASH","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Julius Clinical","has_results":false},{"nct_id":"NCT06476470","title":"Taiwan Interstitial Lung Disease Multi-center Investigation and Registry","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Taichung Veterans General Hospital","has_results":false},{"nct_id":"NCT06372431","title":"PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population of Russia","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05660928","title":"Control of Hypertension and diAbetes in MINas Gerais","phase":"NA","overall_status":"COMPLETED","enrollment_count":5862,"lead_sponsor_name":"Federal University of Minas Gerais","has_results":false},{"nct_id":"NCT07082933","title":"Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and Diabetes","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT04065620","title":"Ambulatory Blood Pressure in HFPEF Outcomes Global Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Hospital Clinic of Barcelona","has_results":false},{"nct_id":"NCT07396792","title":"Screening for Cardiac and Cardiac-associated Pathology Using Single-channel Electrocardiogram","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":4000,"lead_sponsor_name":"I.M. Sechenov First Moscow State Medical University","has_results":false},{"nct_id":"NCT03959748","title":"DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Polish Cardiology Association","has_results":false},{"nct_id":"NCT02126943","title":"OPsumit USers Registry","phase":"","overall_status":"COMPLETED","enrollment_count":2686,"lead_sponsor_name":"Actelion","has_results":false},{"nct_id":"NCT04373863","title":"Assessment of Lifestyle, Blood Pressure, Cholesterol and Glycated Hemoglobin in a Specific Population","phase":"","overall_status":"COMPLETED","enrollment_count":2472,"lead_sponsor_name":"Libbs Farmacêutica LTDA","has_results":false},{"nct_id":"NCT06784687","title":"Evaluation of the Prevalence and Clinical Manifestation of SARS-CoV-2 Infection in a Population of Adult and Pediatric Patients With Congenital Heart Disease","phase":"","overall_status":"COMPLETED","enrollment_count":2376,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT03197688","title":"Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States","phase":"","overall_status":"COMPLETED","enrollment_count":2200,"lead_sponsor_name":"Actelion","has_results":false},{"nct_id":"NCT05566002","title":"Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Chinese Pulmonary Vascular Disease Research Group","has_results":false},{"nct_id":"NCT04930289","title":"Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2000,"lead_sponsor_name":"Paragonix Technologies","has_results":false},{"nct_id":"NCT03730116","title":"Assessment of the Efficacy and Tolerability of the Fixed-dose Combination of Bisoprolol/Perindopril","phase":"","overall_status":"COMPLETED","enrollment_count":1909,"lead_sponsor_name":"Servier Russia","has_results":true},{"nct_id":"NCT03504124","title":"Multicomponent Intervention to Improve Hypertension Control in Central America","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1854,"lead_sponsor_name":"Institute of Nutrition of Central America and Panama","has_results":false},{"nct_id":"NCT05684055","title":"\"Community-based, eHealth Supported Management of Cardiovascular Risk Factors by Lay Village Health Workers (ComBaCaL aHT TwiC 1 & ComBaCaL aHT TwiC 2)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1354,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT04129840","title":"Identifying Most Effective Treatment Strategies to Control Arterial Hypertension in Sub-Saharan Africa","phase":"NA","overall_status":"COMPLETED","enrollment_count":1268,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT03722524","title":"The Use of TrIple Fixed-dose Combination in the Treatment of Arterial Hypertension","phase":"","overall_status":"COMPLETED","enrollment_count":1247,"lead_sponsor_name":"Servier Russia","has_results":true},{"nct_id":"NCT03292094","title":"The African-PREDICT Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1202,"lead_sponsor_name":"North-West University, South Africa","has_results":false},{"nct_id":"NCT07164157","title":"The Risk of Adverse Pregnancy Outcomes for Long-term Exposure to Air Pollution in Pregnant Patients With Pulmonary Hypertension","phase":"","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"Wei Huang","has_results":false},{"nct_id":"NCT05088486","title":"The Role of Genetic Factors in the Development of Arterial Hypertension in the Kazakh Population","phase":"","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"Asfendiyarov Kazakh National Medical University","has_results":false},{"nct_id":"NCT05881447","title":"Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Swiss Tropical & Public Health Institute","has_results":false},{"nct_id":"NCT01106014","title":"Selexipag (ACT-293987) in Pulmonary Arterial Hypertension","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1156,"lead_sponsor_name":"Actelion","has_results":true},{"nct_id":"NCT04820556","title":"Gut Microbiota in Chronic Noncommunicable Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":1084,"lead_sponsor_name":"National Medical Research Center for Therapy and Preventive Medicine","has_results":false},{"nct_id":"NCT03607812","title":"Diagnosis and Management of Arterial Hypertension for Algerian Patients in Current Medical Practice","phase":"","overall_status":"COMPLETED","enrollment_count":1027,"lead_sponsor_name":"Merinal Laboratoires","has_results":false},{"nct_id":"NCT03364244","title":"Revatio Special Investigation for Long-term Use in Pediatric Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1023,"lead_sponsor_name":"Viatris Pharmaceuticals Japan Inc","has_results":false},{"nct_id":"NCT03051763","title":"The Effects of Commercial Air Travel on Patients Suffering From Pulmonary Hypertension","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"University of Giessen","has_results":false},{"nct_id":"NCT03548623","title":"Patient Preference in Blood Pressure Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Roland E. Schmieder","has_results":false},{"nct_id":"NCT05368467","title":"National Registry and Cohort Study of Pulmonary Vascular Disease","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Nanjing First Hospital, Nanjing Medical University","has_results":false},{"nct_id":"NCT04273945","title":"Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":935,"lead_sponsor_name":"Actelion","has_results":false},{"nct_id":"NCT01027949","title":"An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":894,"lead_sponsor_name":"United Therapeutics","has_results":true},{"nct_id":"NCT07218029","title":"A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":815,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT06980064","title":"Wearable Devices Assist in the Detection, Screening, and Management of Major Diseases in Middle-aged and Elderly Populations","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":800,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT03278002","title":"A Registry for Patients Taking Uptravi","phase":"","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Actelion","has_results":false},{"nct_id":"NCT01389206","title":"Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program","phase":"","overall_status":"COMPLETED","enrollment_count":797,"lead_sponsor_name":"Actelion","has_results":false},{"nct_id":"NCT01112306","title":"ACT-293987 in Pulmonary Arterial Hypertension","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":709,"lead_sponsor_name":"Actelion","has_results":true},{"nct_id":"NCT03559608","title":"Arterial Hypertension in Men in the Warmia and Masuria Region","phase":"","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"University of Warmia and Mazury","has_results":false},{"nct_id":"NCT01560624","title":"Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":690,"lead_sponsor_name":"United Therapeutics","has_results":true},{"nct_id":"NCT03626688","title":"A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":687,"lead_sponsor_name":"United Therapeutics","has_results":false},{"nct_id":"NCT01208792","title":"Auto-immunity and Pulmonary Arterial Hypertension","phase":"NA","overall_status":"COMPLETED","enrollment_count":629,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05977933","title":"Assessing the Utility of Submaximal CPET in Treatment Management of PAH","phase":"","overall_status":"UNKNOWN","enrollment_count":550,"lead_sponsor_name":"Shape Medical Systems, Inc.","has_results":false},{"nct_id":"NCT00667823","title":"Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":550,"lead_sponsor_name":"Actelion","has_results":true},{"nct_id":"NCT04656847","title":"PRIDE. Assessment of the Efficacy, Adherence and Tolerability of the Single Pill Combination Bisoprolol/Perindopril","phase":"","overall_status":"COMPLETED","enrollment_count":504,"lead_sponsor_name":"Servier Russia","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}